Telix and ITM Join Forces to Create Radiopharma Powerhouse
Filed with ASX · · 36 pages · English
Telix Pharmaceuticals Limited on 6ix
In the deck
Earlier from Telix Pharmaceuticals
- FDA Approves Telix's Brain Cancer Imaging Drug Pixclara
- Application for quotation of securities - TLX
- FDA Approves Telix Brain Cancer Imaging Drug Pixclara
- Telix to Present at the Morgan Stanley 24th Annual Global Healthcare Conference and H.C. Wainwright 28th Annual Global Investment Conference
- Telix Completes Enrollment in Phase 3 BiPASS Study, Aligns with FDA on NDA Pathway
Later from Telix Pharmaceuticals
- Telix and ITM Join Forces to Create a Radiopharmaceutical Powerhouse
- Grant of waivers of Listing Rule 7.3.4
- Appendix 3Y Change in Director Interest-D Gill
- Change in substantial holding
- FDA Fast Track for BiPASS Pre Biopsy Prostate Imaging
Follow Telix Pharmaceuticals into a list and get an email when it puts out news.
Follow Telix Pharmaceuticals